Business
Remgro Says 1:1 Equity Value Exchange Ratio Envisaged For Mediclinic And Hirslanden
Remgro Says 1:1 Equity Value Exchange Ratio Envisaged For Mediclinic And Hirslanden
About this update from Remgro Limited
Remgro Ltd JSE:REM:JSE: REM - CAUTIONARY: RESTRUCTURING OF INTEREST IN MEDICLINIC HOLDINGS AND SUMMARY OF MEDICLINIC HOLDINGS INTERIM RESULTSREMGRO: RESTRUCTURING OF INTEREST IN MEDICLINIC HOLDINGSREMGRO - 1:1 EQUITY VALUE EXCHANGE RATIO ENVISAGED FOR MEDICLINIC AND HIRSLANDENREMGRO - HY MEDICLINIC REVENUE INCREASES BY 10% DUE TO VOLUME GROWTHREMGRO - HY MEDICLINIC ADJUSTED EBITDA INCREASES BY 23%, MARGIN AT 15.5%